Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
Introduction: C3 glomerulopathy (C3G) is a complex, chronic, ultra rare, progressive primary glomerulonephritis, resulting from alternative complement pathway overactivation, leading to kidney failure in most patients, and frequent recurrence in transplants. Iptacopan (LNP023) is an oral, proximal c...
Saved in:
| Main Authors: | Carla M. Nester, Ute Eisenberger, Alexandre Karras, Moglie le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, Maria José Soler, Junhao Liu, Matthias Meier, Ronda Tawfik, Guido Junge, Andrea Biondani, Angelo J. Trapani, Nicholas J.A. Webb, Edwin K.S. Wong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924019892 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
by: Fernando Caravaca-Fontán, et al.
Published: (2025-04-01) -
Severe hemolysis flare of refractory autoimmune hemolytic anemia with positive complement component C3d responsive to Iptacopan with cyclophosphamide and prednisone: a case report
by: Yawen Zhang, et al.
Published: (2025-12-01) -
Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency
by: Ting Wu, et al.
Published: (2025-08-01) -
Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study
by: Marina Vivarelli, et al.
Published: (2024-01-01) -
Comparison of clinical manifestations and prognosis between two pathological types of obesity-related glomerulopathy
by: LU Hai-tao, et al.
Published: (2019-01-01)